Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.07

+0.9%

Nov 12 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1713)	11/7/2007 10:03:52 AM
From: Jibacoa	Read Replies (1) of 3722

KOOL wants to start the day with the Rt. foot in spite of the general market & the fact that is due to report its 1stQ results at 5PM. bigcharts.marketwatch.com Last month the Cord Blood Registry announced that the FDA had issued a formal 510(k) clearance of the AutoXpress stem cell processing platform, which is the first and only automated processing technology with FDA clearance that can process cord blood collections of any size in a closed environment using sterile materials.(That is in spite of some problems with the system, which are been corrected.<g>) Actually,the published data shows that AXP consistently delivers the highest stem cell recovery rates in the industry. KOOL seems to have found support at the $2.10 level. bigcharts.marketwatch.com In spite of the losses in 2007 & the lower revenues in the 4thQ , things are expected to get better.<g> The short interest increased almost 70% in the last month & is around 18x its ADV. KOOL has no significant LTD, it has a pretty good institutional following with some high quality funds reportedly holding a substantial amount of the float. finance.yahoo.com Bottom line,it seems the R/R is OK at present levels, but I think I will wait for today's report & C.C.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next